Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Alejandro Sweet-Cordero

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Cancer Discovery|May 10, 2013
Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancerRon Chen, E Alejandro Sweet-Cordero
Cancer Discovery|November 3, 2020
An Expanded Tool Kit for Modeling the Oncogenic Functions of KRASKaja Kostyrko, E Alejandro Sweet-Cordero
Molecular Cell|April 30, 2013
The phosphatase PP2A links glutamine to the tumor suppressor p53Dana Gwinn, E Alejandro Sweet-Cordero
Science (New York, N.Y.)|March 16, 2019
The genomic landscape of pediatric cancers: Implications for diagnosis and treatmentE Alejandro Sweet-Cordero, Jaclyn A Biegel
Cancers|June 24, 2022
Synthetic Vulnerabilities in the KRAS PathwayMarta Roman, Elizabeth Hwang, E Alejandro Sweet-Cordero
Advances in Experimental Medicine and Biology|August 9, 2020
Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted TherapiesCourtney Schott, Avanthi Tayi Shah, E Alejandro Sweet-Cordero
Cancer Research|April 12, 2013
Mathematical modeling of tumor cell proliferation kinetics and label retention in a mouse model of lung cancerYanyan Zheng, Helen Moore, Alexandra Piryatinska, et al.
Cold Spring Harbor Perspectives in Medicine|April 2, 2024
Osteosarcoma through the Lens of Bone Development, Signaling, and MicroenvironmentElizabeth P Young, Amanda E Marinoff, Eunice Lopez-Fuentes, et al.
Advanced Healthcare Materials|June 29, 2022
A 3D Osteosarcoma Model with Bone-Mimicking Cues Reveals a Critical Role of Bone Mineral and Informs Drug DiscoveryEva C González Díaz, Alex G Lee, Leanne C Sayles, et al.
Acta Biomaterialia|August 29, 2025
Impact of scaffold material choice on osteosarcoma phenotype and drug responses in 3DCallan E Monette, Jeehee Lee, Abena Peasah, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Cancer Discovery|May 10, 2013
Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancerRon Chen, E Alejandro Sweet-Cordero
Cancer Discovery|November 3, 2020
An Expanded Tool Kit for Modeling the Oncogenic Functions of KRASKaja Kostyrko, E Alejandro Sweet-Cordero
Molecular Cell|April 30, 2013
The phosphatase PP2A links glutamine to the tumor suppressor p53Dana Gwinn, E Alejandro Sweet-Cordero
Science (New York, N.Y.)|March 16, 2019
The genomic landscape of pediatric cancers: Implications for diagnosis and treatmentE Alejandro Sweet-Cordero, Jaclyn A Biegel
Cancers|June 24, 2022
Synthetic Vulnerabilities in the KRAS PathwayMarta Roman, Elizabeth Hwang, E Alejandro Sweet-Cordero
Advances in Experimental Medicine and Biology|August 9, 2020
Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted TherapiesCourtney Schott, Avanthi Tayi Shah, E Alejandro Sweet-Cordero
Cancer Research|April 12, 2013
Mathematical modeling of tumor cell proliferation kinetics and label retention in a mouse model of lung cancerYanyan Zheng, Helen Moore, Alexandra Piryatinska, et al.
Cold Spring Harbor Perspectives in Medicine|April 2, 2024
Osteosarcoma through the Lens of Bone Development, Signaling, and MicroenvironmentElizabeth P Young, Amanda E Marinoff, Eunice Lopez-Fuentes, et al.
Advanced Healthcare Materials|June 29, 2022
A 3D Osteosarcoma Model with Bone-Mimicking Cues Reveals a Critical Role of Bone Mineral and Informs Drug DiscoveryEva C González Díaz, Alex G Lee, Leanne C Sayles, et al.
Acta Biomaterialia|August 29, 2025
Impact of scaffold material choice on osteosarcoma phenotype and drug responses in 3DCallan E Monette, Jeehee Lee, Abena Peasah, et al.
Pageof 7